English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The issue of pharmaceutical drug affordability has moved to the forefront of political and public health concerns over the past decade. The increasing prices of prescription drugs in the United States have denied a class of people access to medication. This problem is not limited to the United States; similar and often more acute dilemmas can be seen in many developing countries. The high prices of pharmaceuticals in the United States can be attributed to several factors. The two most prevalent are the tempQrary monopolies large pharmaceutical companies gain upon receiving patents for their products, and the stringent standards which those drugs must meet under Food and Drug Administration (FDA) regulation.• The monopoiies granted tO the patenting companies are not without justification because those companies must invest millions of dollars in research and development (R&D) of these new drugs.2 The patent monopolies act to fulfill the companies' investment-backed

Understanding the Disparity in Availability of Prescription Drugs in the United States: Compromise May Be the Answer